Parbati Thapa

Parbati Thapa

Auto-generated profile, based on publicly available information

Parbati Thapa

School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
PTParbati Thapa
Parbati Thapa
BKBhuvan KC
Bhuvan KC
SLShaun Wen Huey Lee
Shaun Wen Huey Lee
Juman DujailiJuman Dujaili
Juman Dujaili
SGSudesh Gyawali
Sudesh Gyawali
AAAlian Alrasheedy
Alian Alrasheedy
Background: Pain is a public health problem and affects millions of people globally. Effective pain management is possible through comprehensive pain management guidelines, adequate facilities, and trained healthcare professionals. Therefore, this study aims to analyze the healthcare professionals’ knowledge, attitude, and practice regarding pain management in Western Nepal. Methods: A cross-sectional study was carried out in hospitals of Pokhara, Nepal. Healthcare professionals, including doctors, pharmacists, and nurses, were enrolled. Tools for the study were “The Knowledge and Attitudes Survey Regarding Pain (KASRP)” and a validated practice-based questionnaire. Frequencies and descriptive statistics were used to describe the outcomes. Kruskal–Wallis H-test and Mann-Whitney U-test were used to analyze the association between the mean rank of KASRP score and sample characteristics. A p-value of < 0.05 was considered significant for all statistical tests. Results: A total of 336 healthcare professionals were enrolled in this study (108 medical doctors, 150 nurses, and 78 pharmacists). The mean KASRP scores (% ± SD) obtained by doctors, pharmacists, and nurses were 58.48± 8.98, 53.01± 7.80, and 52.26± 6.39, respectively. A significant difference was found between the KASRP score and sample characteristics (p< 0.001). The pain assessment tool is used by 96 (29%) healthcare professionals every time they meet the patients. Doctors and nurses used it more frequently as compared to pharmacists. Many of the pharmacists, 40 (51%), reported that they counsel the patients on the prescribed medicine (analgesics, NSAIDs, and opioids) every time. As only few participants had already attended a training on pain management, most healthcare professionals, 110 (33%), agreed and 198 (59%) strongly agreed that training related to pain management is needed in Nepal Conclusion: Adequate training and support are required to enhance the knowledge, attitude and ultimately better practice for healthcare professionals regarding pain management in Nepal.

3 November 2023 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Open access
PTParbati Thapa
Parbati Thapa
BKBhuvan Kc
Bhuvan Kc
SGSudesh Gyawali
Sudesh Gyawali
SLSiew Lian Leong
Siew Lian Leong
MIMohamed Izham Mohamed Ibrahim
Mohamed Izham Mohamed Ibrahim
SLShaun Wen Huey Lee
Shaun Wen Huey Lee
Community pharmacists contribute in osteoarthritis management via evidence-based pain management services. However, their roles and impacts on osteoarthritis management in low- and middle-income countries have yet to be explored. This study aims to evaluate the effectiveness of community pharmacist-led educational intervention and medication review among osteoarthritis patients. A 6-month cluster-randomized controlled study was conducted in 22 community pharmacies of Nepal. Patients clinically diagnosed with osteoarthritis, aged 18 years and above, with a poor knowledge level of osteoarthritis and pain management were enrolled in the study. The intervention groups were educated on osteoarthritis and pain management, and had their medications reviewed while control group received usual care. Primary outcomes evaluated for the study were the change in pain levels, knowledge, and physical functional scores at 3 and 6 months. Repeated analyses of covariance were performed to examine the outcomes. A total of 158 participants were recruited for the study. The intervention group reported improvements in pain score (mean difference 0.473, 95 % CI 0.047 to 0.900) at 3 months and the end of the study (mean difference 0.469, 95 % CI 0.047 to 0.891) as compared to control. Similarly, improvement in knowledge scores were observed in the intervention group at 3 months (mean difference 5.320, 95 % CI 4.982 to 5.658) and 6 months (mean difference 5.411, 95 % CI 5.086 to 5.735). No differences were observed in other outcomes, including physical functional score, depression, and quality of life. Community pharmacist-led intervention improved patients' knowledge of osteoarthritis and pain management. While pain scores improved, physical functional score, depression, and quality of life score remained unchanged. ClinicalTrials.gov identifier: NCT05337709.

24 November 2019 in Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
AYAnita Yadav
Anita Yadav
PTParbati Thapa
Parbati Thapa
Purpose. Asthma is a chronic disease which cannot be cured but can be controlled. Although drug therapy is used to relieve and prevent symptoms of asthma and treat exacerbations, still a good asthma control and a better quality of life in many patients is suboptimal due to improper use of inhalation technique. Thus, this interventional study was conducted to evaluate the effect of a pharmacist intervention on asthma control, quality of life and inhaler technique in adult asthmatic patients. Patients and Methods. A total of 72 patients who met the inclusion criteria and agreed to give written consent were enrolled in the study. These patients were randomly divided into two groups i.e., test group (36) and control group (36) by simple block randomization technique. Test group were the interventional groups. Mini Asthma Quality of Life Questionnaire (AQLQ), Asthma Control Questionnaire (ACQ) and structured questionnaires were used to sort the information like quality of life, asthma control and demographic details. They were counselled by the pharmacist about the asthma management and proper use of inhalers. Out of 72 patients, only forty six patients came for follow up after one month. Data were entered and analyzed using Statistical Package for Social Sciences (SPSS) software version 20. Results. A significant change was observed in the mean score of quality of life (p=0.001) in test group as well as control group, however change in the mean score of asthma control in the test group (p=0.001) was more significant as compared to the control group (p=0.099). Inhalation technique was found to be improved significantly after intervention among patients using the metered dose inhaler and dry powder inhaler. Majority of the patients were prescribed with Methylxanthines (24.5%) followed by combined Beta 2 agonists and Inhaled Corticosteroids (21.7%). Conclusion. Pharmacist provided intervention improves the quality of life, asthma control and inhalation technique among asthmatic patients.

1 January 2025 in Pain Research and Management
Verified
Journal Article
Open access
PTParbati Thapa
Parbati Thapa
RTRaj Kumar Thapa
Raj Kumar Thapa
BKBhuvan KC
Bhuvan KC
SGSudesh Gyawali
Sudesh Gyawali
SLShaun Wen Huey Lee
Shaun Wen Huey Lee
Background: Chronic pain is one of the most common reasons for seeking medical care and is associated with depression and reduced quality of life. This study aims to explore the association of depression and quality of life with chronic pain, and medication management among patients with chronic pain. Methods: A cross‐sectional study was conducted among patients visiting the outpatient departments of two tertiary care hospitals in Pokhara, Nepal. Validated questionnaires were used to collect information regarding socio‐demographics, pain intensity (face pain scale), quality of life (EQ‐5D‐3L), depression (PROMIS depression questionnaire) and medications prescribed for pain management. Descriptive statistics, univariate analysis, correlation and multiple regression were used to analyse the data. Results: Three hundred eighty‐five participants were enrolled in the study, and most were females 248 (64.4%). Low back pain ( n = 96; 24.9%) was the most commonly reported pain condition. The participants’ mean pain and quality of life scores were 4.5 ± 1.97 and 0.59 ± 0.37, respectively. NSAIDs were the most prescribed medication. About 25.2% of the participants had mild, 25.5% moderate and 3.4% severe depression. A significant difference in depression and quality of life score was observed between genders ( p < 0.001), among participants with different education levels ( p < 0.001), with comorbidity ( p < 0.001) and pain duration ( p < 0.001). A significant reverse association of quality of life with depression ( β = −0.326, p < 0.001), pain score ( β = −0.292, p < 0.001) and duration of pain ( β = −0.208, p < 0.001) was observed. Conclusion: The quality of life among patients with chronic pain was correlated with the pain score, depression score and duration of pain.

29 September 2015 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
RTRaj Kumar Thapa
Raj Kumar Thapa
PTParbati Thapa
Parbati Thapa
KPKalpana Parajuli-Baral
Kalpana Parajuli-Baral
GKGulam Muhammad Khan
Gulam Muhammad Khan
Health camp is generally organized to provide health care services to the people deprived of health care facilities. The aim of this project was to assess the proportions of disease among attendees of health camp and study the drug prescribing pattern in a free health camp. A case study was performed from 1 day health camp to determine the proportions of disease and drug prescribing pattern. Data collection was performed using log book maintained in the health camp and patient’s demographic details, disease diagnosed and drug prescribed was obtained from same log book. A total of 317 patients were included in the study. The majority of the patients were in the range of 41–50 years. On the basis of study on ethnicity, Brahmins and Chettris, were found to be predominant ethnic groups with gastrointestinal disorders as the major disease. The total number of medications prescribed was 510, with non-steroidal anti-inflammatory drugs (NSAIDs) and antipeptic ulcer drugs being commonly prescribed. The average number of drugs per prescription and the percentage of antibiotics prescribed were 1.6 and 21.4 %, respectively. It was observed that 96.8 % of prescription was by generic names. Likewise, 100 % of prescription included drugs from essential drug list. Majority of the patients were of working age group. Headache and fever were found to be the most prevalent cases and NSAIDs were the most commonly prescribed medications. The drug prescribing pattern of the free health camp complied with WHO recommended prescribing indicators.